Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00762398Terminated

Evaluation of the Accuracy and Precision of the Masimo Labs Pulse-Hemoglobin-Meter Monitor in Surgical Patients

Role: collaborator

NCT01602978Completed

Comparison of Pulse Hemoglobin and Pleth Variability Index

Role: collaborator

NCT01342328Not ApplicableCompleted

Providing "Good Sleep" for ICU Sedation

Role: collaborator

NCT01280097Completed

Study of Sleep and Delirium in the Intensive Care Unit (ICU)

Role: collaborator

All 4 trials loaded